For example, mutations in PTPN11 has been reported to be associated with development of Juvenile Myelomonocytic Leukemia (JMML) [41], acute myeloblastic leukemia (AML) [42], and acute lymphoblastic leukemia (ALL) [43]. This evidence concerns the gene PTPN11 and acute myeloid leukemia.